Johnson & Johnson forward PE JNJ

Share price divided by analysts' consensus earnings for the next twelve months, since 1996.

Today, Oct 23, 2026: 23.4×
10-year median: 17.1×
Against its 10-year history: 98th; percentile: 0 is its lowest day, 100 its highest
10-year range: 14.0× to 25.2×
Peer median: 17.5×

Johnson & Johnson's forward PE is 23.4× as of Oct 23, 2026.

That is above its ten-year median of 17.1×, higher than on 98% of days in the last ten years.

Over that time it ranged from 14.0× in Jan 2025 to 25.2× in Sep 2026.

The median for 7 large drugmakers of a similar size is 17.5×.

Forward PE over time

median 17.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	23.4×	19.4×	25.2×
2025	19.7×	14.0×	20.1×
2024	14.5×	14.4×	17.5×
2023	15.9×	14.8×	18.3×
2022	17.9×	16.3×	18.7×
2021	17.6×	16.4×	18.7×
2020	17.9×	15.6×	20.8×
2019	19.8×	15.2×	19.9×
2018	15.1×	14.9×	18.9×
2017	17.9×	16.0×	18.6×
2016	16.6×	15.1×	18.4×
2015	16.0×	14.8×	18.1×
2014	18.1×	16.1×	18.9×
2013	17.0×	14.1×	17.8×
2012	13.7×	12.4×	14.1×
2011	13.4×	12.2×	13.8×
2010	13.0×	12.3×	14.1×
2009	14.0×	11.2×	14.3×
2008	13.8×	13.2×	17.0×
2007	16.5×	15.1×	16.7×

Against its peers

Companies in Drug Manufacturers - General nearest Johnson & Johnson's size, closest first, today.

Company	Forward PE
JNJJohnson & Johnson	23.4×
ABBVAbbVie	19.0×
MRKMerck	17.5×
LLYEli Lilly and	33.9×
AMGNAmgen	18.6×
GILDGilead Sciences	17.2×
PFEPfizer	10.9×
BMYBristol-Myers Squibb	10.4×
Peer median	17.5×

Where Johnson & Johnson ranks

#34of 51Healthcare stocks with the lowest forward PE

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Johnson & Johnson

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.